
Annual General Meeting

The 2019 Annual General Meeting will be held on Wednesday, April 24, 2019.
Click here for more informationBavarian Nordic is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases.
READ MOREOur pipeline comprises multiple product candidates which are subject to more than 20 ongoing clinical studies in infectious diseases and cancer. Many of our programs are supported by external funding through either private or governmental partnerships.
Read moreBavarian Nordic is committed to providing our shareholders and the media with reliable and transparent information about our business, development programs and results in an open and timely manner
Read moreBavarian Nordic offers a challenging international working environment in which
job satisfaction and personal growth have a high priority.
The 2019 Annual General Meeting will be held on Wednesday, April 24, 2019.
Click here for more information